News for 'SARS'

IIT study finds Covid traces in Sabarmati river, 2 lakes

IIT study finds Covid traces in Sabarmati river, 2 lakes

Rediff.com18 Jun 2021

A recent study by researchers at the Indian Institute of Technology (IIT) Gandhinagar has established the presence of coronavirus in water samples from the Sabarmati river and two lakes in Ahmedabad city of Gujarat.

Covid Delta variant behind bulk of breakthrough infections in India

Covid Delta variant behind bulk of breakthrough infections in India

Rediff.com20 Aug 2021

Breakthrough infections of coronavirus cases comprise a very high proportion of the Delta variant, the INSACOG, a genome sequencing government consortium of laboratories, has said.

Oxford's COVID vaccine 'encouraging' for older age groups

Oxford's COVID vaccine 'encouraging' for older age groups

Rediff.com19 Nov 2020

This means there are now four promising vaccines on the horizon after Pfizer-BioNTech, Sputnik and Moderna already reporting good preliminary data from Phase 3 trials.

20 passengers from UK test positive for COVID-19

20 passengers from UK test positive for COVID-19

Rediff.com22 Dec 2020

According to SOP, those testing positive will be isolated in a separate unit of an institutional facility.

25 UNFORGETTABLE Dilip Kumar songs

25 UNFORGETTABLE Dilip Kumar songs

Rediff.com9 Jul 2021

Sukanya Verma lists 25 unforgettable Dilip Kumar melodies to love and listen to.

'UK strain behind current COVID surge in Delhi'

'UK strain behind current COVID surge in Delhi'

Rediff.com23 Apr 2021

According to the NCDC, 415 cases of the UK strain of coronavirus were found in genomes sequenced in Delhi, followed by 23 cases of the South African strain.

All you need to know about China's deadly coronavirus

All you need to know about China's deadly coronavirus

Rediff.com21 Jan 2020

Common symptoms of the novel coronavirus (nCoV) strain, which has infected more than 300 people since the outbreak in Wuhan in December, include respiratory symptoms such as fever, cough, shortness of breath and breathing difficulties, the WHO said

Johnson & Johnson says its Covid shot neutralises Delta variant

Johnson & Johnson says its Covid shot neutralises Delta variant

Rediff.com2 Jul 2021

In the ensemble trial, Johnson & Johnson's vaccine was 85 per cent effective against severe/critical disease and demonstrated protection against hospitalisation and death. The vaccine was consistently effective across all regions studied globally, including in South Africa and Brazil, where there was a high prevalence of rapidly emerging Beta and Zeta variants during the study period.

Omicron overtakes Delta; less severe but not mild: WHO

Omicron overtakes Delta; less severe but not mild: WHO

Rediff.com12 Jan 2022

"Omicron has been detected in all countries where we have good sequencing and it's likely to be in all countries around the world. It is quickly, in terms of its circulation, overtaking Delta. And so Omicron is becoming the dominant variant that is being detected," Kerkhove said during a virtual questions and answers session.

'Emergence of another coronavirus is inevitable'

'Emergence of another coronavirus is inevitable'

Rediff.com13 May 2020

'The worst case scenario is a rebound of the virus.' 'Life is not going to be what it was.' 'Life as we know it has changed forever.' 'The new normal therefore is test, trace and treat.'

Mask mandate can be removed for now, say experts

Mask mandate can be removed for now, say experts

Rediff.com8 Apr 2022

The assurance comes as India's Covid graph dips -- on Friday 1,109 new coronavirus infections were reported -- and also one case of a new Covid strain in Mumbai.

First Covid case may have emerged in China in Oct 2019: Study

First Covid case may have emerged in China in Oct 2019: Study

Rediff.com25 Jun 2021

The research, published in the journal PLOS Pathogens on Thursday, suggests that the first case of COVID-19 arose between early October and mid-November, 2019 in China, with the most likely date of origin being November 17.

'Biggest need of the hour': Sania Mirza urges people to stay at home

'Biggest need of the hour': Sania Mirza urges people to stay at home

Rediff.com23 Mar 2020

Indian tennis player Sania Mirza expressed concerns over the spread of coronavirus and urged people to stay at home saying that it is the 'biggest need of the hour'.

Delhi's Covid surge no sign of 4th wave, say health experts

Delhi's Covid surge no sign of 4th wave, say health experts

Rediff.com19 Apr 2022

Though Covid cases are rising in Delhi and its satellite towns, the focus should be on hospital admissions that have remained the same or changed just marginally, say several scientists, underscoring that the uptick is not an indication of a fourth wave in the country at this point.

Ram Lal Anand College terminates jailed professor G N Saibaba's service; wife to move court

Ram Lal Anand College terminates jailed professor G N Saibaba's service; wife to move court

Rediff.com3 Apr 2021

Saibaba, an assistant professor of English, was suspended after his arrest by the Maharashtra Police in 2014. His wife and daughters were receiving half of his salary since the arrest.

Covaxin phase 3 trial data to be published in July: Bharat Biotech

Covaxin phase 3 trial data to be published in July: Bharat Biotech

Rediff.com9 Jun 2021

Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial will publish the data in July following that the company will be applying for the full licensure of Covaxin.

Breakthrough Covid infections in India within expected numbers: INSACOG

Breakthrough Covid infections in India within expected numbers: INSACOG

Rediff.com1 Sep 2021

When a person gets an infection even after being vaccinated against it, it is called a breakthrough case.

Elite athletes at risk of coronavirus spread to lungs

Elite athletes at risk of coronavirus spread to lungs

Rediff.com29 Apr 2020

The research suggests that due to strenuous exercise, elite athletes are more likely to inhale virus particles and direct them to the lower areas of the lung.

COVID-19 tests may yield false negative if used too early: Study

COVID-19 tests may yield false negative if used too early: Study

Rediff.com11 Jun 2020

Explaining how RT-PCR tests may yield a false negative results, the scientists said, when a swab misses collecting cells infected with the virus, or if virus levels are very low early during the infection, some tests can produce negative results.

Lockdown, containment measures successful: ICMR sero-survey

Lockdown, containment measures successful: ICMR sero-survey

Rediff.com12 Jun 2020

The first part of the study conducted by the Indian Council of Medical Research (ICMR) revealed that 0.73 per cent of the population surveyed showed evidence of past exposure to SARS-CoV-2, and that urban slum population was the most vulnerable to the infection, ICMR Director General Balram Bhargava said at a press conference.

ICMR approves TB machines for COVID-19 testing

ICMR approves TB machines for COVID-19 testing

Rediff.com10 Apr 2020

The ICMR has validated 'TruenatTM beta CoV test on TruelabTM workstation' and has recommended it as a screening test,the apex health research body said on Friday.

Nortje out of quarantine after false COVID-19 scare

Nortje out of quarantine after false COVID-19 scare

Rediff.com16 Apr 2021

The Proteas speedster, a star performer for DC in the last edition, had tested positive for COVID-19 while in quarantine. But was retested and came out negative in three RT-PCR results.

Coronavirus mutations may not make it more infectious: Study

Coronavirus mutations may not make it more infectious: Study

Rediff.com26 May 2020

Coronaviruses, like other RNA viruses, can develop mutations in three different ways: by mistake from copying errors during viral replication, through interactions with other viruses infecting the same cell, or they can be induced by RNA modification systems which are part of host immunity, the researchers explained.

Strain of coronavirus in pigs can jump to humans: Study

Strain of coronavirus in pigs can jump to humans: Study

Rediff.com14 Oct 2020

Researchers said outbreaks of such an illness have the potential to wreak economic havoc in many countries across the globe that rely on the pork industry.

Covaxin maker to pay compensation in case of side effects

Covaxin maker to pay compensation in case of side effects

Rediff.com16 Jan 2021

"The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine," the consent form said.

Vaxed pregnant women pass antibodies to babies: Study

Vaxed pregnant women pass antibodies to babies: Study

Rediff.com23 Sep 2021

Women who receive the mRNA COVID-19 vaccine during pregnancy pass high levels of antibodies to their babies, according to a study.

'Dengue outbreak may aggravate COVID-19 crisis'

'Dengue outbreak may aggravate COVID-19 crisis'

Rediff.com10 Jul 2020

The impact of a 'dengue-COVID-19' season would entail two different diagnostic tests and extract a huge toll on patients too, each disease making the other more complicated to deal with and perhaps more fatal.

No one safe until all vaccinated for Covid: Johns Hopkins scientist

No one safe until all vaccinated for Covid: Johns Hopkins scientist

Rediff.com22 Apr 2022

Vaccine inequity remains an issue in India, where less than 2 per cent of the population has received a Covid booster

USFDA denies Covaxin emergency use nod, to take 'full approval' route

USFDA denies Covaxin emergency use nod, to take 'full approval' route

Rediff.com11 Jun 2021

In a setback that could potentially delay the launch of Bharat Biotech's Covid-19 vaccine Covaxin in USA, the Food and Drug Administration there has "recommended" Ocugen Inc, the US partner of the Indian vaccine maker, to go for Biologics Licence Application (BLA) route with additional data, nixing hopes of Emergency Use Authorisation.

Covid deaths could touch 1 million by August: Lancet

Covid deaths could touch 1 million by August: Lancet

Rediff.com8 May 2021

If that outcome were to happen, the Modi government would be responsible for presiding over a self-inflicted national catastrophe.

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Rediff.com13 May 2021

The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.

'No indication Omicron is more infectious or lethal'

'No indication Omicron is more infectious or lethal'

Rediff.com30 Nov 2021

'Mortality or hospitalisation has not increased in South Africa because of the new variant.' 'There is nothing to show so far that it is more infectious.' 'I am of the opinion that at the moment, there is no reason to panic.'

China warns UK against 'interference' on Hong Kong

China warns UK against 'interference' on Hong Kong

Rediff.com21 Jul 2020

The Chinese Embassy in London and the Chinese ambassador to the UK issued strong statements condemning the UK's move as a disregard for its representations and 'blatant' interference in its internal affairs.

Unplanned vaccination can promote mutant strains: Experts to PM

Unplanned vaccination can promote mutant strains: Experts to PM

Rediff.com10 Jun 2021

A group of public health experts, including doctors from All India Institute of Medical Sciences and members from the national taskforce on COVID-19, have said that mass, indiscriminate and incomplete vaccination can trigger emergence of mutant strains and recommended that there is no need to inoculate those who had documented coronavirus infection.

FAQ: Is it safe to take antibody cocktail for Covid-19?

FAQ: Is it safe to take antibody cocktail for Covid-19?

Rediff.com10 Jun 2021

According to medical practitioners, the treatment is especially useful in controlling disease among those who have not received the vaccine or got only one shot and also the high-risk contacts of a patient.

Do people ever recover from COVID-19?

Do people ever recover from COVID-19?

Rediff.com29 Sep 2020

'People who have already got diabetes or heart disease or high blood pressure seem to be more badly affected by the disease.'

India saw 18% drop in new Covid cases, 13% fall in deaths from Oct 11-17

India saw 18% drop in new Covid cases, 13% fall in deaths from Oct 11-17

Rediff.com20 Oct 2021

India reported an 18 per cent decrease in the new COVID-19 cases along with a 13 per cent decline in the number of deaths during the week of October 11 to 17, the World Health Organisation has said, highlighting that all the regions globally, except the European region, reported a fall in new weekly cases of the deadly virus.

Covid vax tweak can help against new variants: Guleria

Covid vax tweak can help against new variants: Guleria

Rediff.com20 Dec 2021

The COVID-19 vaccines can be "tweaked" to provide protection against new variants of the virus, All India Institute of Medical Sciences (AIIMS), Delhi, Director Dr Randeep Guleria said.

PM reviews preparations for vaccination against COVID-19

PM reviews preparations for vaccination against COVID-19

Rediff.com30 Jun 2020

The PM directed officials to evaluate various technology tools to ensure efficient and timely vaccination in due course of time. He also emphasised that detailed planning for such large scale vaccination should be undertaken immediately.

Covaxin found to neutralise 617 Covid variant: Dr Fauci

Covaxin found to neutralise 617 Covid variant: Dr Fauci

Rediff.com28 Apr 2021

The New York Times on Tuesday said Covaxin works by teaching the immune system to make antibodies against the SARS-CoV-2 coronavirus. The antibodies attach to viral proteins, such as the so-called spike proteins that stud its surface.